Editorial
doi: 10.1093/infdis/jit658.
Epub 2013 Nov 27.
A paradigm shift: vaccine-induced antibodies as an immune correlate of protection against herpes simplex virus type 1 genital herpes
Affiliations
- PMID: 24285847
- DOI: 10.1093/infdis/jit658
Item in Clipboard
Editorial
A paradigm shift: vaccine-induced antibodies as an immune correlate of protection against herpes simplex virus type 1 genital herpes
J Infect Dis.
2014 Mar.
No abstract available
Keywords: HSV-2 vaccine; T-cells; antibody; genital herpes; glycoprotein D.
Comment on
-
Correlate of immune protection against HSV-1 genital disease in vaccinated women.J Infect Dis. 2014 Mar;209(6):828-36. doi: 10.1093/infdis/jit651. Epub 2013 Nov 27. J Infect Dis. 2014. PMID: 24285844 Free PMC article. Clinical Trial.
Similar articles
-
Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.Viral Immunol. 2006 Summer;19(2):220-36. doi: 10.1089/vim.2006.19.220. Viral Immunol. 2006. PMID: 16817765
-
Correlate of immune protection against HSV-1 genital disease in vaccinated women.J Infect Dis. 2014 Mar;209(6):828-36. doi: 10.1093/infdis/jit651. Epub 2013 Nov 27. J Infect Dis. 2014. PMID: 24285844 Free PMC article. Clinical Trial.
-
Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 Vaccine.J Infect Dis. 2021 Nov 16;224(9):1509-1519. doi: 10.1093/infdis/jiab139. J Infect Dis. 2021. PMID: 33718970 Free PMC article.
-
Vaccine value profile for herpes simplex virus.Vaccine. 2024 Jul 25;42(19S1):S82-S100. doi: 10.1016/j.vaccine.2024.01.044. Epub 2024 May 24. Vaccine. 2024. PMID: 39003018 Review.
-
Vaccines for Herpes Simplex: Recent Progress Driven by Viral and Adjuvant Immunology.Methods Mol Biol. 2020;2060:31-56. doi: 10.1007/978-1-4939-9814-2_2. Methods Mol Biol. 2020. PMID: 31617171 Review.
Cited by
-
Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.J Virol. 2014 Nov;88(21):12612-22. doi: 10.1128/JVI.01930-14. Epub 2014 Aug 20. J Virol. 2014. PMID: 25142599 Free PMC article.
-
Herpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections.Curr Clin Microbiol Rep. 2015 Sep 1;2(3):125-136. doi: 10.1007/s40588-015-0020-4. Epub 2015 Jul 1. Curr Clin Microbiol Rep. 2015. PMID: 27114893 Free PMC article.
-
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits.Vaccines (Basel). 2020 Apr 6;8(2):169. doi: 10.3390/vaccines8020169. Vaccines (Basel). 2020. PMID: 32268575 Free PMC article.
-
Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.J Virol. 2015 Sep;89(18):9213-31. doi: 10.1128/JVI.01213-15. Epub 2015 Jun 24. J Virol. 2015. PMID: 26109729 Free PMC article.
-
Anti-glycoprotein g antibodies of herpes simplex virus 2 contribute to complete protection after vaccination in mice and induce antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.Viruses. 2014 Nov 12;6(11):4358-72. doi: 10.3390/v6114358. Viruses. 2014. PMID: 25398047 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
